[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Nephrostomy Devices Market Size, Share & Trends Analysis Report By Product (Guidewires, Drainage Tubes, Nephrostomy Catheters, Sheath Dilators), By End Use (Hospitals), By Region, And Segment Forecasts, 2024 - 2030

September 2024 | 100 pages | ID: NBB19DC41EE7EN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 3 Business Days

Natural Language Generation Market Growth & Trends

The global natural language generation market size is expected to reach USD 2.5 billion by 2030, registering to grow at a CAGR of 21.8% from 2024 to 2030 according to a new report by Grand View Research, Inc. The NLG technique deals with the production and generation of speech and text. There is a wide range of applications of natural language generation such as the conversion of an analytics report in natural language, which can be directly embedded within a dashboard and used to deliver critical insights to more people within an organization quickly. NLG-based tools are finding applications across an increasing set of applications as companies realize the vast benefits of these tools in gaining easy access to rich business information that can help in making data-driven decisions.

An increased use of NLG tools is being found in chatbots. The natural language processing capabilities of these tools make chatbots interact more humanly. NLG enables chatbots to deliver personalized user experience for resolution of a query, booking a complaint, or virtual assistance for processes done online, which enables businesses to enhance their customer experience. NLG capabilities also help create technical as well as non-technical content such as product description, contracts, and internal communications with much ease and at a lower cost.

The adoption of NLG has helped in increasing business efficiency across various business processes. This has significantly increased the adoption of natural language generation across several sectors. The NLG market is likely to significantly benefit from the rising demand for NLG tools in the banking, financial services, and insurance sector in the near future.

Natural Language Generation Market Report Highlights
  • The software segment dominated the market with a market share of 66.3% in 2023. Natural language generation software helps data analysis scientists and non-technical people process information and data with the help of deep learning and helps generate actionable insights based on digital data. This application of natural language generation in various industries and the launch of advanced solutions is expected to drive segmental growth demand over the forecast period.
  • The risk & compliance management segment accounted for the largest market share of 23.0% in 2023. NLG plays a crucial role in automating the generation of reports, alerts, and insights to ensure regulatory compliance and manage risks effectively.
  • The cloud segment was the most dominant segment, with a global market share of 67.0% in 2023. Benefits offered by the cloud deployment, such as quick setup, low operational cost, and flexibility in pricing models, are major factors driving the market growth.
  • Large enterprises dominated the market and accounted for a market share of hold the most dominant position with a global market share of 67.4% in 2023.
  • The BFSI segment dominated the market and accounted for a market share of 21.8% in 2023. The natural language generation in the BFSI sector can help automate financial reports, create regulatory compliance documents, and enhance customer service through automated responses.
CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
  1.3.1. Information Procurement
  1.3.2. Information or Data Analysis
  1.3.3. Market Formulation & Data Visualization
  1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
  1.4.1. List of Data Sources

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

CHAPTER 3. NEPHROSTOMY DEVICES MARKET VARIABLES, TRENDS, & SCOPE

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
  3.3.1. Market Drivers Analysis
  3.3.2. Market Restraints Analysis
3.4. Nephrostomy Devices Market Analysis Tools
  3.4.1. Porter’s Analysis
    3.4.1.1. Bargaining power of the suppliers
    3.4.1.2. Bargaining power of the buyers
    3.4.1.3. Threats of substitution
    3.4.1.4. Threats from new entrants
    3.4.1.5. Competitive rivalry
  3.4.2. PESTEL Analysis
    3.4.2.1. Political landscape
    3.4.2.2. Economic and Social landscape
    3.4.2.3. Technological landscape
    3.4.2.4. Environmental landscape
    3.4.2.5. Legal landscape

CHAPTER 4. NEPHROSTOMY DEVICES MARKET: PRODUCT ESTIMATES & TREND ANALYSIS

4.1. Segment Dashboard
4.2. Nephrostomy Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Guidewires
  4.3.1. Guidewires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Drainage Tubes
  4.4.1. Drainage Tubes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Nephrostomy Catheters
  4.5.1. Nephrostomy Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Sheath Dilators
  4.6.1. Sheath Dilators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Others
  4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 5. NEPHROSTOMY DEVICES MARKET: END USE ESTIMATES & TREND ANALYSIS

5.1. Segment Dashboard
5.2. Nephrostomy Devices Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
5.3. Hospitals
  5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Emergency Clinics
  5.4.1. Emergency Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Ambulatory Surgical Centers (ASCs)
  5.5.1. Ambulatory Surgical Centers (ASCs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 6. NEPHROSTOMY DEVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS

6.1. Nephrostomy Devices Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
  6.2.1. North America Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.2.2. U.S.
    6.2.2.1. U.S. Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.2.3. Canada
    6.2.3.1. Canada Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.2.4. Mexico
    6.2.4.1. Mexico Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
  6.3.1. Europe Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.2. UK
    6.3.2.1. UK Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.3. Germany
    6.3.3.1. Germany Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.4. France
    6.3.4.1. France Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.5. Italy
    6.3.5.1. Italy Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.6. Spain
    6.3.6.1. Spain Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.7. Denmark
    6.3.7.1. Denmark Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.8. Sweden
    6.3.8.1. Sweden Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.9. Norway
    6.3.9.1. Sweden Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
  6.4.1. Asia Pacific Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4.2. Japan
    6.4.2.1. Japan Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4.3. China
    6.4.3.1. China Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4.4. India
    6.4.4.1. India Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4.5. Australia
    6.4.5.1. Australia Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4.6. South Korea
    6.4.6.1. South Korea Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4.7. Thailand
    6.4.7.1. Thailand Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
  6.5.1. Latin America Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.5.2. Brazil
    6.5.2.1. Brazil Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.5.3. Argentina
    6.5.3.1. Argentina Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
  6.6.1. Middle East and Africa Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.6.2. South Africa
    6.6.2.1. South Africa Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.6.3. Saudi Arabia
    6.6.3.1. Saudi Arabia Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.6.4. UAE
    6.6.4.1. Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.6.5. Kuwait
    6.6.5.1. Kuwait Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 7. COMPETITIVE LANDSCAPE

7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
  7.4.1. Boston Scientific Corporation
    7.4.1.1. Participant’s Overview
    7.4.1.2. Financial Performance
    7.4.1.3. Product Benchmarking
    7.4.1.4. Recent Developments/ Strategic Initiatives
  7.4.2. Teleflex Incorporated.
    7.4.2.1. Participant’s Overview
    7.4.2.2. Financial Performance
    7.4.2.3. Product Benchmarking
    7.4.2.4. Recent Developments/ Strategic Initiatives
  7.4.3. Cardinal Health.
    7.4.3.1. Participant’s Overview
    7.4.3.2. Financial Performance
    7.4.3.3. Product Benchmarking
    7.4.3.4. Recent Developments/ Strategic Initiatives
  7.4.4. BD
    7.4.4.1. Participant’s Overview
    7.4.4.2. Financial Performance
    7.4.4.3. Product Benchmarking
    7.4.4.4. Recent Developments/ Strategic Initiatives
  7.4.5. Cook Medical
    7.4.5.1. Participant’s Overview
    7.4.5.2. Financial Performance
    7.4.5.3. Product Benchmarking
    7.4.5.4. Recent Developments/ Strategic Initiatives
  7.4.6. B. Braun Melsungen AG
    7.4.6.1. Participant’s Overview
    7.4.6.2. Financial Performance
    7.4.6.3. Product Benchmarking
    7.4.6.4. Recent Developments/ Strategic Initiatives
  7.4.7. Coloplast Group
    7.4.7.1. Participant’s Overview
    7.4.7.2. Financial Performance
    7.4.7.3. Product Benchmarking
    7.4.7.4. Recent Developments/ Strategic Initiatives
  7.4.8. Olympus Corporation
    7.4.8.1. Participant’s Overview
    7.4.8.2. Financial Performance
    7.4.8.3. Product Benchmarking
    7.4.8.4. Recent Developments/ Strategic Initiatives
  7.4.9. Argon Medical Devices.
    7.4.9.1. Participant’s Overview
    7.4.9.2. Financial Performance
    7.4.9.3. Product Benchmarking
    7.4.9.4. Recent Developments/ Strategic Initiatives
  7.4.10. UreSil, LLC
    7.4.10.1. Participant’s Overview
    7.4.10.2. Financial Performance
    7.4.10.3. Product Benchmarking
    7.4.10.4. Recent Developments/ Strategic Initiatives


More Publications